Biomerica (BMRA) EPS (Basic) Growth (1y) (2011 - 2026)
Biomerica (BMRA) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 13.85% |
| 10 | Biomerica | 4.77 Mn | 3.44 Mn | -44,000.00 | 10.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 10.12% |
| Nov 30, 2025 | -2.25% |
| Aug 31, 2025 | 100.12% |
| May 31, 2025 | -14.67% |
| Feb 28, 2025 | 46.84% |
| Nov 30, 2024 | 38.06% |
| Aug 31, 2024 | -16.25% |
| May 31, 2024 | 55.43% |
| Feb 29, 2024 | 6.84% |
| Nov 30, 2023 | 25.87% |
| Aug 31, 2023 | 57.45% |
| May 31, 2023 | -18.30% |
| Feb 28, 2023 | -1,406.32% |
| Nov 30, 2022 | -35.23% |
| Aug 31, 2022 | -27.41% |
| May 31, 2022 | 49.20% |
| Feb 28, 2022 | 95.45% |
| Nov 30, 2021 | 38.85% |
| Aug 31, 2021 | 22.94% |
| May 31, 2021 | -239.85% |